Pycnogenol Blood Pressure Meta-analysis: What the Evidence Says

Quick Answer

Pycnogenol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• However, despite their efficacy, hypoglycaemic medications are associated with varying costs and side effect profiles that may influence a patient's decision to seek other interventions, including herbal medicine. [Li Ethan (2025); evidence level 3]
• There is limited evidence on how herbal medicine may interact with Western pharmaceuticals. [Li Ethan (2025); evidence level 3]
• However, even in high-intensity training, which poses an increased risk for rhabdomyolysis compared to other exertive activities, CK levels rarely exceed 100,000 U/L. [Muacevic Alexander (2025); evidence level 4]
• At recommended dosages, pine bark extract has a favorable safety profile, with minimal side effects and no evidence of severe muscle toxicity, as supported by comprehensive systematic reviews and meta-analyses. [Muacevic Alexander (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For pycnogenol blood pressure meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Li Ethan (2025). The efficacy and safety of herbal medicines for glycaemic control and insulin resistance in individuals with type 2 diabetes: an umbrella review. DOI: 10.1186/s12906-025-05059-7. PMCID: PMC12481776. PMID: 41029669. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12481776/
• Muacevic Alexander (2025). Rhabdomyolysis Associated With Excess Pine Bark Extract: A Case Report. DOI: 10.7759/cureus.93956. PMCID: PMC12588601. PMID: 41200632. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12588601/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.